US 8221737
Hepatitis C virus inhibitors
granted A61KA61K31/397A61K31/41
Quick answer
US patent 8221737 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/397, A61K31/41, A61K31/4184, A61K31/4192